Affiliation:
1. Glaxo Research and Development Ltd., Stevenage, Hertfordshire, United Kingdom.
Abstract
A simple, robust assay system which can be used to screen for inhibitors of mycobacterial growth has been developed. A strain of the rapidly growing saprophyte Mycobacterium aurum is used as the test organism. Inhibition of its growth is highly predictive of activity against Mycobacterium tuberculosis, which cannot itself be used in screening because of its growth characteristics and highly infectious nature. The viability of M. aurum in the presence of a test sample is monitored by measuring the uptake of radiolabelled uracil into the cells. In a microtiter plate format, the screen has the potential for testing several thousand samples per day.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference22 articles.
1. A rapid method for the evaluation of new antituberculous agents;Ashtekar D. R.;Chemotherapy (Basel),1987
2. Tuberculosis in patients with human immunodeficiency virus infection;Barnes P. F.;N. Engl. J. Med.,1991
3. Tuberculosis: commentary on a reemergent killer;Bloom B. R.;Science,1992
4. Mycobacteria: laboratory methods for testing drug sensitivity and resistance;Canetti G.;Bull. W. H. O.,1963
5. The 7H11 medium for the cultivation of mycobacteria;Cohn M. L.;Am. Rev. Respir. Dis.,1968
Cited by
94 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献